Executive Director, Head of Managed Markets

MannKind Corporation (Nasdaq: MNKD) is a biopharmaceutical company dedicated to transforming chronic disease care through innovative, patient-centric solutions. Focused on cardiometabolic and orphan lung diseases, we develop and commercialize treatments that address serious unmet medical needs, including diabetes, pulmonary hypertension, and fluid overload in heart failure and chronic kidney disease. With deep expertise in drug-device combinations, MannKind aims to deliver therapies designed to fit seamlessly into daily life.

The Executive Director, Head of Managed Markets leads MannKind's managed markets strategy and payer account execution across the portfolio. This role translates corporate and brand objectives into prioritized payer strategies that protect and expand economically sustainable patient access, support new product and indication launches, and enable prescription pull-through within existing coverage pathways.

Reporting to the Senior Vice President, Access & Reimbursement, the Executive Director directly manages three Directors and directs external payer consultants. The role is accountable for coordinated engagement across national and regional commercial health plans, pharmacy benefit managers (PBMs), Medicare Part D plans, and state and managed Medicaid programs. The Executive Director partners with Patient Support, Trade, Contracting, Government Pricing, Analytics, Sales, Marketing, Medical Affairs, HEOR, Finance, Legal and Compliance.

Lead portfolio-wide managed markets strategy, including channel priorities, account segmentation, resource allocation, launch readiness and annual operating plans aligned with the SVP, Access & Reimbursement.

Manage, coach and develop three Directors; establish account ownership, objectives, execution standards and development plans. Build a coordinated team with clear decision rights and escalation pathways.

Direct payer consultants through defined scopes of work, account assignments, deliverables and budgets. Integrate consultant activity with Director account plans and internal governance.

Own strategic national and regional payer account planning. Personally engage senior payer executives and support Directors in complex negotiations, formulary reviews and critical access escalations.

Develop payer contracting recommendations, including offer design, rebate structures and access conditions, with Contracting, Finance and Government Pricing. Evaluate access gains against net revenue and government-pricing implications; secure approvals within established authority.

Advance clinically and economically grounded payer value propositions with Medical Affairs and HEOR. Ensure account teams are prepared for formulary and pharmacy and therapeutics committee reviews.

Balance opportunities to improve coverage with practical pull-through under existing policies. Partner with Patient Support and field reimbursement resources to identify recurring PA, exception and appeal barriers and support appropriate, patient-specific documentation pathways.

Partner with Trade and Patient Support to align payer strategy with pharmacy-network requirements, distribution pathways, affordability support and prescription-to-paid-claim execution. This role does not replace their operational ownership.

Lead payer readiness for new products and indications, including account engagement plans, evidence needs, coverage scenarios, contracting options and cross-functional milestones.

Partner with Analytics to maintain a consistent view of payer policies, access restrictions, contract economics and account opportunities. Track coverage quality, utilization management, access-related conversion barriers and business impact, not activity alone.

Provide actionable marketplace intelligence and recommendations to senior leadership on payer priorities, competitive developments, policy changes, risks and investment tradeoffs.

Manage the managed markets operating budget and consultant spending. Maintain an enterprise perspective and ensure all payer engagement and contracting activities comply with applicable requirements and company policies.

Bachelor's degree in Health Sciences, Business, Marketing or a related field; advanced degree preferred.

Substantial progressive pharmaceutical or biotechnology market access experience, including successful national payer account management, contracting strategy and leadership of experienced account professionals.

Demonstrated ability to lead Director-level colleagues and external consultants, establish accountability and translate strategy into coordinated execution.

Established relationships and demonstrated experience with major PBMs and national and regional health plans; breadth beyond a single payer account.

Deep understanding of commercial, Medicare Part D, state Medicaid and managed Medicaid access dynamics, including formulary processes, utilization management and reimbursement pathways.

Strong command of rebate economics, gross-to-net tradeoffs and the government-pricing implications of commercial contracting, in partnership with subject-matter experts.

Ability to translate clinical, HEOR and pharmacoeconomic evidence into credible payer value discussions and actionable account strategies.

Experience supporting launches and aligning payer strategy with patient support, specialty pharmacy, field reimbursement and prescription pull-through.

Executive presence, sound judgment and the ability to influence senior payer stakeholders and cross-functional leadership.

Teamwork & Leadership: Builds a cohesive team, develops leaders and establishes clear accountability across internal and external partners.

Execution: Prioritizes the highest-value opportunities, makes disciplined decisions under uncertainty and follows through on measurable outcomes.

Solution Maker: Connects payer needs, clinical value and business economics to practical access strategies.

Continuous Improvement: Uses data and operational feedback to improve account execution, resource deployment and patient access.

Enterprise Awareness: Balances brand objectives with portfolio economics, organizational capabilities and compliance obligations.

Ability to travel up to 50% of the time.